Zealand Pharma A/S (22Z)
XETR
Real-time Data
07:00 AM
Day's Range
32.8452 wk Range
31.45Overview - 22Z - Zealand Pharma A/S
Key Statistics
Valuation
Enterprise Value
-1.54B
P/E (Trailing)
‪6.85‬
Price / Sales (TTM)
‪0.52‬
Price / Book
‪1.03‬
EV / EBITDA
‪-4.97‬
Profitability
Gross Margin
‪100.00%‬
Profit Margin
‪59.02%‬
Operating Margin
‪85.92%‬
Return on Assets
‪7.80%‬
Return on Equity
‪16.31%‬
Ownership
Shares Outstanding
69.39M
Float
55.21M
Held by Insiders
‪0.53%‬
Held by Institutions
‪40.76%‬
Price stats
Beta
‪0.59‬
50-Day Avg
‪39.77‬
200-Day Avg
‪39.77‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 22Z - Zealand Pharma A/S
Peers - 22Z - Zealand Pharma A/S
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
- 22ZXETRZealand Pharma A/S2.44BMarket Cap-84.66%52-week change6.85P/E (Trailing)‪59.02%‬Profit Margin
- ANLXETRAnalog Devices, Inc.166.81BMarket Cap+39.03%52-week change45.97P/E (Trailing)‪29.78%‬Profit Margin
- 0QFXETRModerna Inc.65.00BMarket Cap+87.29%52-week change-22.43P/E (Trailing)‪-141.42%‬Profit Margin
- 22UAXETRBioNTech SE American Depositary Share21.89BMarket Cap+2.60%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
- BBZAXETRBB Biotech AG3.29BMarket Cap+42.63%52-week change13.32P/E (Trailing)‪127.31%‬Profit Margin
- BV3XETRBavarian Nordic A/S2.18BMarket Cap-8.37%52-week change11.17P/E (Trailing)‪24.33%‬Profit Margin
- AYJXETRValneva SE504.65MMarket Cap-72.87%52-week change70.98P/E (Trailing)‪-110.29%‬Profit Margin
Profile Summary - 22Z - Zealand Pharma A/S
About
Zealand Pharma A/S is a biotechnology company focused on the discovery, design, and development of innovative peptide-based medicines. Founded in 1998 and headquartered in Søborg, Denmark, it leverages over 25 years of expertise in peptide research to address unmet medical needs in obesity, rare diseases, and chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
